Assignee
QI ZHANKAI
CN·1 granted patent·4 pending applications·0 citations·filing 2019–2023
Top patents by PatentIndex Score
5 records- 0144US2024245757A1Use of Phospholipase A2 from Elapidae snakes in the treatment of diabetic nephropathyQI ZHANKAI·Filed 2023·Application pending·0 cites
- 0227US2020093866A1Use of selected single cobrotoxin molecule as an analgesicQI ZHANKAI·Filed 2019·Application pending·0 cites
- 0326US2023045015A1Use of Cobra neurotoxin polypeptide molecule in the treatment of nephropathy proteinuriaQI ZHANKAI·Filed 2020·Application pending·0 cites
- 0426US2021008177A1Elapidae neurotoxin enhances opioid analgesic effect and inhibits opioid induced hyperalgesia and toleranceQI ZHANKAI·Filed 2020·Application pending·0 cites
- 0512USD1074572SCar glasses boxQI ZHANKAI·Filed 2021·Granted May 13, 2025·0 cites·1 claims
Join the waitlist — get patent alerts
Get an alert when QI ZHANKAI files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →